Lecia Bushak

Editor, Pharma at MM+M

new york, new york, united states

Publications:

CCampaign

mmmm-online.com

pprweek.co.uk

pprweek.com

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

About

I'm an experienced, award-winning multimedia journalist, audio reporter and producer, and editor with a demonstrated history of working in the public media (NPR/PBS) and journalism world. I have a double major in Journalism and Studio Art from New York University.

Featured Articles

Five things for pharma marketers to know for Tuesday, January 13, 2025

Eli Lilly struck a $1 billion deal with Nvidia to build a new AI-powered research lab, the drugmaker’s latest step in expanding its use of AI in discovering new therapies. The lab will employ Nvidia’s new Vera Rubin AI chips. (Reuters) Food and Drug Admin... See more

mmm-online.com•Lecia Bushak•Jan 13, 2026

3 regulatory issues for pharma marketers to keep an eye on in 2026

Key takeaways Pharma leaders cite regulatory change as one of the top trends likely to impact their corporate strategies in 2026. While staffing and funding cuts at HHS may slightly slow down drug approvals, new FDA approval pathways may speed up innovati... See more

mmm-online.com•Lecia Bushak•Jan 9, 2026

Real Chemistry launches new advisory practice to elevate pharma's corporate brand reputation

Real Chemistry has launched a new advisory practice that will seek to offer guidance to healthcare and pharma companies from a corporate communications and reputation standpoint. The agency unveiled the advisory, dubbed RC Resolve, in advance of the JPMor... See more

mmm-online.com•Lecia Bushak•Jan 9, 2026

The state of GenAI in pharma marketing: AI could erode consumers' trust in pharma brands

Key takeaways 2026 will be the year for pharma marketers to move from AI experimentation to holistic integration. Pharma has been slower to adapt fully AI-generated commercials, with many marketers emphasizing the need for real patient representation. Gen... See more

mmm-online.com•Lecia Bushak•Jan 5, 2026

Pfizer's birth control injection has a new safety label, reflecting potential brain tumors - MM+M - Medical Marketing and Media

Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning label for Depo-Provera — Pfizer’s birth control injection t... See more

mmm-online.com•Lecia Bushak•Dec 18, 2025

Bylined Articles

HARO Queries

Portfolio

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Social Media

Pitching Guidelines

Keep it short (under 200 words)
Include credentials and links
Use subject lines with query title

Pitching Guidelines

Quick Stats

Followers

447

Articles37

Last Article21 hours ago

Stats

Education

Bachelor Of Fine Arts, Journalism, Studio Art at New York UniversityGraduated: 2012

Education

Lecia Bushak

Is this you?

About

Featured Articles

Five things for pharma marketers to know for Tuesday, January 13, 2025

3 regulatory issues for pharma marketers to keep an eye on in 2026

Real Chemistry launches new advisory practice to elevate pharma's corporate brand reputation

The state of GenAI in pharma marketing: AI could erode consumers' trust in pharma brands

Pfizer's birth control injection has a new safety label, reflecting potential brain tumors - MM+M - Medical Marketing and Media

Is this you?

Social Media

Education

Connect with journalists.

Connect with journalists.

Featured Articles

Five things for pharma marketers to know for Tuesday, January 13, 2025

3 regulatory issues for pharma marketers to keep an eye on in 2026

Real Chemistry launches new advisory practice to elevate pharma's corporate brand reputation

The state of GenAI in pharma marketing: AI could erode consumers' trust in pharma brands

Pfizer's birth control injection has a new safety label, reflecting potential brain tumors - MM+M - Medical Marketing and Media

Social Media

Education